IMMUNOCORE HLDGS ADS/1 (6YG) — Cash Flow Quality Index

Latest as of March 2025: 0.09x

IMMUNOCORE HLDGS ADS/1 (6YG) has a Cash Flow Quality Index of 0.09x as of March 2025. Operating cash flow of €435.00K is below net income of €5.02 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore long-term investment intensity of IMMUNOCORE HLDGS ADS/1 to see how much of total assets are deployed in long-term investments.

Cash Flow Quality Index

0.09x

Operating CF / Net Income

Operating Cash Flow

€435.00K

EUR

Net Income

€5.02 Million

EUR

Data as of

Mar 2025

Most recent filing

Annual Cash Flow Quality Index for IMMUNOCORE HLDGS ADS/1 (None–None)

Year-by-year earnings quality comparison for IMMUNOCORE HLDGS ADS/1. For live market cap and the full company financial profile, see market value of IMMUNOCORE HLDGS ADS/1.

Year	Quality Index	Operating CF (EUR)	Net Income	YoY Change

Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.